The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations
Open accessAbstract
TMC278 is a diarylpyrimidine (DAPY) nonnucleoside reverse transcriptase inhibitor (NNRTI) that is highly effective in treating wild-type and drug-resistant HIV-1 infections in clinical trials at relatively low doses (∼25–75 mg/day). We have determined the structure of wild-type HIV-1 RT complexed with TMC278 at 1.8 Å resolution, using an RT crystal form engineered by systematic RT mutagenesis. This high-resolution structure reveals that the cyanovinyl group of TMC278 is positioned in a hydrophobic tunnel connecting the NNRTI-binding pocket to the nucleic acid-binding cleft. The crystal structures of TMC278 in complexes with the double mutant K103N/Y181C (2.1 Å) and L100I/K103N HIV-1 RTs (2.9 Å) demonstrated that TMC278 adapts to bind mutant RTs. In the K103N/Y181C RT/TMC278 structure, loss of the aromatic ring interaction caused by the Y181C mutation is counterbalanced by interactions between the cyanovinyl group of TMC278 and the aromatic side chain of Y183, which is facilitated by an ∼1.5 Å shift of the conserved Y 183 MDD motif. In the L100I/K103N RT/TMC278 structure, the binding mode of TMC278 is significantly altered so that the drug conforms to changes in the binding pocket primarily caused by the L100I mutation. The flexible binding pocket acts as a molecular “shrink wrap” that makes a shape complementary to the optimized TMC278 in wild-type and drug-resistant forms of HIV-1 RT. The crystal structures provide a better understanding of how the flexibility of an inhibitor can compensate for drug-resistance mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside Inhibitors
Spence, R. A., Kati, W. M., Anderson, K. S., & Johnson, K. A. (1995) · Science · doi:10.1126/science.7532321 · Cited by 522
Das, K., Clark, Lewi, P. J., Heeres, J., de Jonge, M. R., Koymans, L. M. H., Vinkers, H. M., Daeyaert, F., Ludovici, D. W., Kukla, M. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030558s · Cited by 514
Self-citationHigh resolution structures of HIV-1 RT from four RT–inhibitor complexes
Ren, J., Esnouf, R., Garman, E., Somers, D., Ross, C., Kirby, I., Keeling, J., Darby, G., Jones, Y., Stuart, D., et al. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0495-293 · Cited by 502
The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.
Rodgers, D. W., Gamblin, S. J., Harris, B. A., Ray, S., Culp, J. S., Hellmig, B., Woolf, D. J., Debouck, C., & Harrison, S. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1222 · Cited by 378
Janssen, P. A. J., Lewi, P. J., Arnold, E., Daeyaert, F., de Jonge, M., Heeres, J., Koymans, L., Vinkers, M., Guillemont, J., Pasquier, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040840e · Cited by 347
Self-citationHsiou, Y., Ding, J., Das, K., Clark, Jr., Hughes, S., & Arnold, E. (1996) · Structure · doi:10.1016/s0969-2126(96)00091-3 · Cited by 289
Self-citationDas, K., Lewi, P. J., Hughes, S. H., & Arnold, E. (2005) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2004.07.001 · Cited by 225
Self-citationEvolution of anti-HIV drug candidates. Part 3: diarylpyrimidine (DAPY) analogues
Ludovici, D. W., De Corte, B. L., Kukla, M. J., Ye, H., Ho, C. Y., Lichtenstein, M. A., Kavash, R. W., Andries, K., de Béthune, M.-P., Azijn, H., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00412-7 · Cited by 185
Self-citationReview of HIV-1 reverse transcriptase three-dimensional structure: Implications for drug design
Nanni, R. G., Ding, J., Jacobo‐Molina, A., Hughes, S. H., & Arnold, E. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171659 · Cited by 153
Self-citationHimmel, D. M., Das, K., Clark, A. D., Hughes, S. H., Benjahad, A., Oumouch, S., Guillemont, J., Coupa, S., Poncelet, A. J., Csoka, I., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0500323 · Cited by 150
Self-citationLindberg, J., Sigurðsson, S., Löwgren, S., Andersson, H. O., Sahlberg, C., Noréen, R., Fridborg, K., Zhang, H., & Unge, T. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2002.02811.x · Cited by 136
Short-term antiviral activity of TMC278 – a novel NNRTI – in treatment-naive HIV-1-infected subjects
Goebel, F. D., Yakovlev, A., Pozniak, A., Vinogradova, E., Boogaerts, G., Hoetelmans, R. M. W., de Béthune, M., Peeters, M., & Woodfall, B. (2006) · AIDS · doi:10.1097/01.aids.0000242818.65215.bd · Cited by 128
Guillemont, J., Pasquier, E., Palandjian, P., Vernier, D., Gaurrand, S., Lewi, P. J., Heeres, J., de Jonge, M. R., Koymans, L. M. H., Daeyaert, F. F. D., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040838n · Cited by 122
Self-citationDas, K., Sarafianos, S. G., Clark, A. D., Boyer, P. L., Hughes, S. H., & Arnold, E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.08.097 · Cited by 88
Self-citationRen, J., Nichols, C. E., Chamberlain, P. P., Weaver, K. L., Short, S. A., & STAMMERS, D. K. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.12.055 · Cited by 81
Recent developments for the efficient crystallographic refinement of macromolecular structures
Brünger, A. T., Adams, P. D., & Rice, L. M. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80152-8 · Cited by 79
Ren, J., Nichols, C. E., Chamberlain, P. P., Weaver, K. L., Short, S. A., Chan, J. H., Kleim, J., & STAMMERS, D. K. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061117m · Cited by 72
Otwinowski, Z., Minor, W., Borek, D., & Cymborowski, M. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000833 · Cited by 63
Lewis, P. J., de Jonge, M. R., Daeyaert, F. F. D., Koymans, L. M. H., Vinkers, M. H., Heeres, J., Janssen, P. A. J., Arnold, E., Das, K., Clark, A. D., et al. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1025313705564 · Cited by 51
Self-citationAspects of successful drug discovery and development
Pauwels, R. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.007 · Cited by 50
Clark, A. D., Jacobo‐Molina, A., Clark, P. K., Hughes, S. H., & Arnold, E. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)62017-6 · Cited by 29
Self-citationHeeres, J., & Lewi, P. J. (2007) · Advances in antiviral drug design · doi:10.1016/s1075-8593(06)05006-4 · Cited by 24
Self-citation
Cited by
DOCK 6: Impact of new features and current docking performance
Allen, W. J., Balius, T. E., Mukherjee, S., Brozell, S. R., Moustakas, D. T., Lang, P. T., Case, D. A., Kuntz, I. D., & Rizzo, R. C. (2015) · Journal of Computational Chemistry · doi:10.1002/jcc.23905 · Cited by 833
Sarafianos, S. G., Marchand, B., Das, K., Himmel, D. M., Parniak, M. A., Hughes, S. H., & Arnold, E. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.071 · Cited by 535
Self-citationThe structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 424
de Béthune, M.-P. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.008 · Cited by 401
Applications of 2D IR Spectroscopy to Peptides, Proteins, and Hydrogen-Bond Dynamics
Kim, Y. S., & Hochstrasser, R. M. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp8113978 · Cited by 313
Metadata
- Authors
- Das, K., Bauman, J. D., Clark, A. D., Frenkel, Y. V., Lewi, P. J., Shatkin, A. J., Hughes, S. H., & Arnold, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-02-05
- Volume
- 105
- Issue
- 5
- Pages
- 1466-1471
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2064570326
- Cited by
- 343
- References
- 26
- FWCI
- 15.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.